MDMA-assisted therapy (MDMA-AT) for PTSD sparked debate, primarily focused on concerns of safety and efficacy. But no matter how novel a treatment may be, if it is inaccessible to the millions of people who need it, its relevance becomes insignificant. The post Breaking Barriers: Why Accessibility Matters in PTSD Treatment Beyond MDMA appeared first on…
The reintroduction of the “Improving Seniors’ Timely Access to Care Act” marks a critical step toward modernizing the prior authorization process within Medicare Advantage plans. So, what does this mean for patients and providers moving forward? The post Navigating the Government’s Medicare Advantage Prior Authorization Changes appeared first on MedCity News.
Insilico Medicine’s idiopathic pulmonary fibrosis drug led to dose-dependent improvement in lung function in a mid-stage study. Meanwhile, Pliant Therapeutics and PureTech Health are also making Phase 2 progress while Boehringer Ingelheim is planning regulatory submission supported by its IPF drug’s Phase 3 data. The post AI-Designed Insilico Drug Flashes Signs of Efficacy in Lung…
Meditech is integrating Suki’s AI assistant into more than a dozen rural health systems, including St. Mary’s Healthcare in New York and Decatur County Memorial Hospital in Indiana. The post When It Comes to AI, Rural Doctors Have FOMO — Meditech & Suki Are Teaming Up to Address This appeared first on MedCity News.
In two letters, U.S. representatives and senators called for an extension of the enhanced premium tax credits, which are set to expire in 2025 and have lowered costs for those purchasing coverage on the marketplace. The post 195 Congress Members Call for Extension of Enhanced Premium Tax Credits appeared first on MedCity News.
Zevra Therapeutics drug Miplyffa is now FDA approved for Niemann-Pick disease type C, a lysosomal storage disorder. The affirmative regulatory decision took into account additional clinical data generated since the FDA turned down a submission for the drug in 2021. The post FDA Approval Makes a Zevra Drug the First Therapy for Rare and Fatal…
Active investors chose Healthy Young Minds as the Pitch Perfect winner at the INVEST Digital Health Conference in Dallas. See how the company’s CEO accepted the award. The post Video: INVEST Digital Health Pitch Perfect Winner Accepting Award appeared first on MedCity News.
Many are already experimenting with AI in narrow settings. But in order to expand deployment, it’s important to understand the most practical AI opportunities with the greatest ROI. Here are four high-impact opportunities that can boost staff efficiency and improve the patient experience. The post From Charting to Patient Intake: The 4 Biggest Opportunities for…
We need to continue investing in research for early stage, localized prostate cancer, develop treatments that balance efficacy with quality-of-life considerations, ensure diverse representation in clinical trials, and listen to patients and incorporate their perspectives into treatment development and decision-making. The post Prostate Cancer Management – We Need Better Options for Early-Stage Disease appeared first…
During a panel discussion at the MedCity News INVEST Digital Health Conference, executives shared the top challenges they’re facing in the consumer diagnostic testing space. These challenges include funding and encouraging behavior change. The post What Are the Challenges in Building a Consumer-Focused Diagnostic Testing Startup? appeared first on MedCity News.